Article

President Bush signs eye trauma measure

Washington, DC-President Bush signed into law the National Defense Authorization Act, including the Military Eye Trauma measure, on Jan. 28.

Washington, DC-President Bush signed into law the National Defense Authorization Act, including the Military Eye Trauma measure, on Jan. 28. It is designed to improve the ability of the Department of Defense (DoD) and the Veterans Health Administration to treat members of the military who have suffered serious eye injuries while on active duty.

The measure establishes a Center of Excellence within the DoD to improve the tracking, diagnosis, treatment, and follow-up for service members who have incurred eye injuries. It also creates a formal registry to house electronic records and to enable the DoD and Department of Veterans Affairs to share patient information. The measure passed by Congress does not provide funding for the center or registry, however.

The American Academy of Ophthalmology, the Blinded Veterans Association, and other veterans’ service organizations supported the legislation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.